Peppermint tea sipped slowly throughout the day offers gentle, continuous support
This is analogous to the evidence pathway followed for liraglutide (LEADER trial, NEJM 2016) and semaglutide (SUSTAIN-6 trial, NEJM 2016), which established cardiovascular benefit for those agents only after large, long-term CVOTs reported [6] The heart rate increase warrants ongoing surveillance, particularly in patients with pre-existing cardiac conditions Phase 3 trials are currently underway (see ClinicalTrials.gov and the EU Clinical Trials Information System, CTIS, for registered studies)
While facing these lawsuits, Eli Lilly and Novo Nordisk have initiated legal actions against compounding pharmacies, seen by some as efforts to deflect accountability for the adverse effects, blaming the compounding manufacturers for creating sub-par medications that have caused the side effects
The retatrutide dosage chart provides specific protocol frameworks